FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt

Follow Drugslib on

By I. Edwards HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 18, 2025.

via HealthDay

FRIDAY, July 18, 2025 — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell some of its electronic cigarettes in the United States.

The U.S. Food and Drug Administration (FDA) said that it will allow Juul to market its e-cigarette device and tobacco and menthol refill cartridges.

The agency said the products may help adult smokers quit traditional cigarettes.

The FDA decision comes after years of back-and-forth with the company, which was blamed for a rise in teen vaping.

“Americans who use nicotine deserve an orderly, reliable market in which they can confidently choose from a wide array of smokefree nicotine products that are high-quality, innovative, backed by rigorous research, made in FDA-inspected manufacturing facilities, and marketed and sold responsibly,” Juul CEO K.C. Crosthwaite said in a statement.

Still, the FDA stressed that approval doesn’t mean the products are safe, a spokesperson for the U.S. Department of Health and Human Services (HHS) told The Washington Post.

The agency will “closely monitor compliance with robust restrictions to limit youth exposure to marketing, and will act appropriately if [the] company fails to comply with requirements,” the spokesperson added.

Juul’s slim e-cigarettes became popular in 2015, especially among teens, in part to their wide choice of fruity flavored cartridges. But the company faced major backlash and lawsuits, with critics accusing it of marketing to kids.

The FDA ordered Juul’s products off the market in 2022, but the ban was put on hold while the company challenged it in court. In 2024, the FDA reversed the ban, but it didn’t fully authorize sales until now.

Juul, which narrowly avoided bankruptcy after the 2022 ban, has since settled lawsuits for billions of dollars. The company says it is working to prevent minors using the products.

“It is a big step in the wrong direction to authorize sales of the product that was responsible for this public health crisis in the first place,” Yolonda Richardson, president of the Campaign for Tobacco-Free Kids, told The Post.

Harold Wimmer, president of the American Lung Association, told The Post he was especially concerned about Juul’s menthol pods staying on the market. He called for a full ban on all flavored tobacco products.

A recent survey by the U.S. Centers for Disease Control and Prevention found that about 1.6 million U.S. middle and high school students use e-cigarettes. Nearly 90% said they use flavored ones.

While teen vaping has fallen off since peaking in 2019, health officials say flavored vapes — many of them illegally sold — remain a serious concern.

Juul’s authorization dovetails with a July 14 study out of Australia that found vaping might be more effective than traditional nicotine replacement therapies in helping people quit smoking.

Sources

  • The Washington Post, July 17, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-07-19 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords